Should we use PCSK9 inhibitors?
I’ve just been asked about PCSK9 inhibitors. These “Pesky” medications, which include the agents Alirocumab and Evolocumab, lower LDL cholesterol by inactivating a protein in the liver called called proprotein … Continue reading
August 10, 2016 · 6 Comments
Recent Comments